A recent study reveals that people who stop using new slimming jabs like semaglutide or tirzepatide may regain lost weight at a significantly accelerated pace than those who halt traditional lifestyle programs.
Findings released in a major health publication shows that while obese individuals often shed a large proportion of their body weight while undergoing treatment, the mass returns at an average rate of nearly a kilo each month once they quit.
"People using these drugs need to be cognizant of the danger of quick weight regain when the medication ends," cautioned researcher Dr. Susan Jebb.
This pace of regain means a return to original mass within about 18 months.
Analyzing Treatments
The study, which examined 37 of studies involving over 9,000 of patients, contrasted the effects of these new drugs with other pills.
Scientists emphasize that individuals who shed pounds through diet and exercise typically have a less rapid weight regain—approximately 100 grams monthly—post-intervention.
Understanding the Fast Rebound
Nutrition scientists propose the mode of action of the drugs is key to understanding the heightened regain.
These medications copy a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Sustained high doses of the hormone levels far above than the body's typical production could lead to the system to produce less of its endogenous GLP-1, and may also lessen responsiveness to its actions," noted Dr. Adam Collins, a nutrition expert.
"Discontinuation of this hormone supplement leads to hunger is unsuppressed, making binge eating far more likely."
A Lifelong Condition?
The NHS advise the injections for individuals with weight-linked health risks, accompanied by recommended lifestyle changes.
A number of clinicians argue that, due to the high risk of relapse, the therapy is often ongoing.
This perspective is echoed by drug manufacturers, who state that the results "underscore the chronic character of obesity," similar to managing diseases like high blood pressure.
User Testimonies
Individuals who have come off the jabs report a sudden resurgence of appetite.
"I experienced a trigger that goes on and you're instantly ravenous," described a patient.
This challenge is exacerbated if users have not developed permanent dietary or behavioural modifications during treatment.
Growing Adoption
Recent estimates suggest that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with interest being substantial.
- Use is more common among females compared to males.
- The 40s and 50s age group shows the greatest level of interest.
- A large proportion obtain the drugs through private prescriptions rather than public health services.
In conclusion, experts stress that while the jabs are powerful tools for shedding pounds, they are not a standalone cure and long-term success hinges on integrated behavioural support.
